DGAP-Adhoc: Eckert & Ziegler: Defining the parameters of the public share buyback offer


 
DGAP-Ad-hoc: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Share Buyback Eckert & Ziegler: Defining the parameters of the public share buyback offer 21-Jun-2018 / 18:45 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Berlin, June 21, 2018 - As already published in an ad hoc announcement, the Executive Board of Eckert & Ziegler AG decided on June 1, 2018 to launch a public share buyback offer to acquire up to 125,000 own shares. With the resolution of June 21, 2018, the Executive Board has now defined the other parameters of the public share buyback offer. The offer period starts on June 26, 2018 and ends on July 10, 2018, 24:00 (CEST). During this period, the Eckert & Ziegler shareholders of the Company may offer their shares at a purchase price (not including any ancillary purchasing costs) of EUR 39.00 per no-par bearer share of Eckert & Ziegler AG. This offer price corresponds to a premium of 3.3 % on the closing price in XETRA trading on June 21, 2018. If more than 125,000 shares are submitted for repurchase under the offer, the acceptance declarations will be taken into consideration proportional to the ratio of 125,000 shares to the total number of shares submitted by the shareholders for repurchase. Further details of the public share buyback offer can be found in the offer document, which the Company is expected to publish on June 26, 2018 in the Federal Official Gazette [Bundesanzeiger] and on its website www.ezag.de > Investors. Your contact for inquiries: Eckert & Ziegler AG, Karolin Riehle, Investor Relations Robert-Rössle-Str. 10, 13125 Berlin Tel.: +49 (0) 30 / 94 10 84-138, karolin.riehle@ezag.de, www.ezag.de --------------------------------------------------------------------------- 21-Jun-2018 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: Eckert & Ziegler Strahlenund Medizintechnik AG Robert-Rössle-Str.10 13125 Berlin Germany Phone: 49 30 941084-138 Fax: 49 30 941084-112 E-mail: karolin.riehle@ezag.de Internet: www.ezag.de ISIN: DE0005659700 WKN: 565970 Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange End of Announcement DGAP News Service --------------------------------------------------------------------------- 697851 21-Jun-2018 CET/CEST


Die wichtigsten Finanzdaten auf einen Blick
  2012 2013 2014 2015 2016 2017 2018 2019e
Umsatzerlöse1 120,00 117,14 127,26 139,75 137,94 138,63 168,71 180,00
EBITDA1,2 27,48 22,07 20,10 26,98 24,97 26,62 32,14 32,30
EBITDA-Marge3 22,90 18,84 15,79 19,31 18,10 19,20 19,05 17,94
EBIT1,4 19,73 12,82 12,96 18,22 16,23 17,97 23,39 23,50
EBIT-Marge5 16,44 10,94 10,18 13,04 11,77 12,96 13,86 13,06
Jahresüberschuss1 10,29 9,09 6,50 10,37 9,79 15,12 16,89 19,00
Netto-Marge6 8,58 7,76 5,11 7,42 7,10 10,91 10,01 10,56
Cashflow1,7 16,57 14,65 10,65 16,23 19,83 26,83 21,21 22,50
Ergebnis je Aktie8 1,95 1,72 1,28 2.03 1,81 2,78 3,12 4,10
Dividende8 0,60 0,60 0,60 0,60 0,66 0,80 1,20 1,40
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2018 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: BDO

INVESTOR-INFORMATIONEN
©boersengefluester.de
Eckert & Ziegler
WKN Kurs in € Einschätzung Börsenwert in Mio. €
565970 182,200 Halten 964,38
KGV 2020e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
43,38 17,11 2,503 91,00
KBV KCV KUV EV/EBITDA
7,42 45,47 5,72 28,740
Dividende '19 in € Dividende '20e in € Div.-Rendite '19e
in %
Hauptversammlung
1,40 1,40 0,77 17.06.2020
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
12.05.2020 13.08.2020 12.11.2019 31.03.2020
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
7,63% 43,77% 195,30% 180,74%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Eckert & Ziegler Strahlen- und Medizintechnik AG  ISIN: DE0005659700 können Sie bei DGAP abrufen

Medtech , 565970 , EUZ , XETR:EUZ